Trial · NCT00092547
Adverse events76
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 76
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Injection site erythema | General disorders | qHPV Vaccine in Base: Vaccine Phase and Follow-up | 237 | 1,165 | 323 |
| other | Injection site erythema | General disorders | Placebo in Base: Vaccine Phase and Follow-up | 78 | 584 | 109 |
| other | Injection site erythema | General disorders | qHPV Vaccine in Base: Extension and Long-term Follow-up | 0 | 932 | 0 |
| other | Injection site erythema | General disorders | qHPV Vaccine in Extension: Extension and Long-term Follow-up | 1 | 481 | 1 |
| other | Injection site pain | General disorders | qHPV Vaccine in Base: Vaccine Phase and Follow-up | 853 | 1,165 | 1,705 |
| other | Injection site pain | General disorders | Placebo in Base: Vaccine Phase and Follow-up | 268 | 584 | 434 |
| other | Injection site pain | General disorders | qHPV Vaccine in Base: Extension and Long-term Follow-up | 0 | 932 | 0 |
| other | Injection site pain | General disorders | qHPV Vaccine in Extension: Extension and Long-term Follow-up | 3 | 481 | 3 |
| other | Injection site swelling | General disorders | qHPV Vaccine in Base: Vaccine Phase and Follow-up | 241 | 1,165 | 336 |
| other | Injection site swelling | General disorders | Placebo in Base: Vaccine Phase and Follow-up | 45 | 584 | 63 |
| other | Injection site swelling | General disorders | qHPV Vaccine in Base: Extension and Long-term Follow-up | 0 | 932 | 0 |
| other | Injection site swelling | General disorders | qHPV Vaccine in Extension: Extension and Long-term Follow-up | 1 | 481 | 1 |
| other | Pyrexia | General disorders | qHPV Vaccine in Base: Vaccine Phase and Follow-up | 100 | 1,165 | 114 |
| other | Pyrexia | General disorders | Placebo in Base: Vaccine Phase and Follow-up | 44 | 584 | 60 |
| other | Pyrexia | General disorders | qHPV Vaccine in Base: Extension and Long-term Follow-up | 0 | 932 | 0 |
| other | Pyrexia | General disorders | qHPV Vaccine in Extension: Extension and Long-term Follow-up | 0 | 481 | 0 |
| other | Headache | Nervous system disorders | qHPV Vaccine in Base: Vaccine Phase and Follow-up | 221 | 1,165 | 297 |
| other | Headache | Nervous system disorders | Placebo in Base: Vaccine Phase and Follow-up | 111 | 584 | 163 |
| other | Headache | Nervous system disorders | qHPV Vaccine in Base: Extension and Long-term Follow-up | 0 | 932 | 0 |
| other | Headache | Nervous system disorders | qHPV Vaccine in Extension: Extension and Long-term Follow-up | 0 | 481 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00092547/events